News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,857 Results
Type
Article (41942)
Company Profile (265)
Press Release (694636)
Multimedia
Podcasts (95)
Webinars (21)
Section
Business (205808)
Career Advice (2044)
Deals (35710)
Drug Delivery (135)
Drug Development (81858)
Employer Resources (173)
FDA (16635)
Job Trends (15046)
News (348688)
Policy (33334)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2626)
Accelerated approval (53)
ADA (44)
Adcomms (27)
Allergies (185)
Alliances (49827)
ALS (223)
Alzheimer's disease (1824)
Antibody-drug conjugate (ADC) (494)
Approvals (17068)
Artificial intelligence (700)
ASCO (327)
Autoimmune disease (329)
Automation (58)
Bankruptcy (362)
Best Places to Work (11664)
BIOSECURE Act (20)
Biosimilars (231)
Biotechnology (170)
Bladder cancer (200)
Brain cancer (75)
Breast cancer (787)
Cancer (6173)
Cardiovascular disease (492)
Career advice (1739)
Career pathing (44)
CAR-T (350)
CDC (57)
Celiac Disease (3)
Cell therapy (940)
Cervical cancer (53)
Clinical research (71511)
Collaboration (2150)
Company closure (5)
Compensation (1461)
Complete response letters (84)
COVID-19 (2770)
CRISPR (112)
C-suite (1192)
Cystic fibrosis (155)
Data (8449)
Decentralized trials (3)
Denatured (28)
Depression (167)
Dermatology (94)
Diabetes (652)
Diagnostics (7020)
Digital health (62)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (342)
Drug pricing (207)
Drug shortages (31)
Duchenne muscular dystrophy (297)
Earnings (92562)
Editorial (67)
Employer branding (21)
Employer resources (152)
Events (120972)
Executive appointments (1108)
FDA (20523)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (35)
Funding (1803)
Gene editing (239)
Generative AI (60)
Gene therapy (736)
GLP-1 (1091)
Government (5021)
Grass and pollen (7)
Guidances (415)
Healthcare (19291)
Hematology (192)
HIV (87)
Huntington's disease (58)
IgA nephropathy (110)
Immunology and inflammation (293)
Immuno-oncology (101)
Indications (203)
Infectious disease (3129)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (311)
Interviews (322)
IPO (16717)
IRA (50)
Job creations (3675)
Job search strategy (1441)
JPM (58)
Kidney cancer (20)
Labor market (109)
Layoffs (571)
Leadership (41)
Legal (8019)
Liver cancer (104)
Longevity (34)
Lung cancer (821)
Lymphoma (461)
Machine learning (61)
Management (59)
Manufacturing (1105)
MASH (205)
Medical device (14037)
Medtech (14189)
Mergers & acquisitions (20285)
Metabolic disorders (1621)
mRNA (219)
Multiple sclerosis (194)
NASH (17)
Neurodegenerative disease (443)
Neuropsychiatric disorders (106)
Neuroscience (3418)
Neurotech (1)
NextGen: Class of 2026 (6547)
Non-profit (4582)
Now hiring (79)
Obesity (751)
Opinion (292)
Ovarian cancer (234)
Pain (264)
Pancreatic cancer (334)
Parkinson's disease (385)
Partnered (33)
Patents (619)
Patient recruitment (726)
Peanut (66)
People (60018)
Pharmaceutical (59)
Pharmacy benefit managers (33)
Phase 1 (22274)
Phase 2 (31490)
Phase 3 (23468)
Pipeline (9465)
Policy (326)
Postmarket research (2581)
Preclinical (9484)
Press Release (65)
Prostate cancer (329)
Psychedelics (54)
Radiopharmaceuticals (342)
Rare diseases (1128)
Real estate (6004)
Recruiting (70)
Regulatory (25903)
Reports (56)
Research institute (2435)
Resumes & cover letters (354)
Rett syndrome (42)
RNA editing (23)
RSV (88)
Schizophrenia (181)
Series A (300)
Series B (221)
Service/supplier (12)
Sickle cell disease (117)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3661)
State (2)
Stomach cancer (18)
Supply chain (132)
Tariffs (89)
The Weekly (65)
Vaccines (1132)
Venture capital (116)
Weight loss (484)
Women's health (133)
Worklife (20)
Date
Today (41)
Last 7 days (597)
Last 30 days (2902)
Last 365 days (30388)
2026 (15019)
2025 (30234)
2024 (35293)
2023 (40162)
2022 (51322)
2021 (55908)
2020 (54354)
2019 (46924)
2018 (35311)
2017 (32254)
2016 (31696)
2015 (37745)
2014 (31479)
2013 (26493)
2012 (28708)
2011 (29395)
2010 (27472)
Location
Africa (757)
Alabama (93)
Alaska (7)
Arizona (361)
Arkansas (14)
Asia (40047)
Australia (6585)
California (13791)
Canada (3930)
China (1444)
Colorado (590)
Connecticut (604)
Delaware (425)
Europe (86828)
Florida (2064)
Georgia (441)
Hawaii (3)
Idaho (64)
Illinois (1122)
India (94)
Indiana (623)
Iowa (23)
Japan (574)
Kansas (132)
Kentucky (51)
Louisiana (58)
Maine (76)
Maryland (1644)
Massachusetts (9868)
Michigan (371)
Minnesota (744)
Mississippi (6)
Missouri (155)
Montana (33)
Nebraska (29)
Nevada (146)
New Hampshire (85)
New Jersey (3615)
New Mexico (30)
New York (3606)
North Carolina (1741)
North Dakota (9)
Northern California (6958)
Ohio (412)
Oklahoma (23)
Oregon (41)
Pennsylvania (2752)
Puerto Rico (29)
Rhode Island (51)
South America (1123)
South Carolina (86)
South Dakota (2)
Southern California (5454)
Tennessee (221)
Texas (2203)
United States (48624)
Utah (407)
Vermont (1)
Virginia (333)
Washington D.C. (81)
Washington State (1101)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
736,857 Results for "sinoveda canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel) Securing Canadian rights to a proprietary advanced clinical-stage product candidate developed in Canada adds to Medexus’s medium-term product pipeline and helps build a North American allo-HSCT franchise
June 10, 2026
·
16 min read
GLP-1
Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’
Analysts will be watching as a generic version of semaglutide—marketed by Novo Nordisk as Wegovy for weight loss—launches in Canada as a test case for future price erosion in the U.S.
April 29, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. secure public reimbursement of ABILIFY ASIMTUFII®
March 4, 2026
·
6 min read
Press Releases
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia
June 9, 2026
·
6 min read
Press Releases
Phiusion Labs Inc. Announces Strategic Distribution Partnership with Proteos Biotech S.L. for PBSerum® in the United States and Canada
April 13, 2026
·
2 min read
Press Releases
Ivy Parks of BD-Canada Appointed Chair of the Medtech Canada Board of Directors
May 8, 2026
·
3 min read
Press Releases
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada
May 20, 2026
·
10 min read
Press Releases
Kye Pharmaceuticals Announces the Availability of Dyanavel® XR Tablets Across Canada for the Treatment of ADHD
June 8, 2026
·
5 min read
Press Releases
Pharmascience Canada announces the launch of ᴾʳpms-DOLUTEGRAVIR
April 29, 2026
·
1 min read
Press Releases
Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar
April 7, 2026
·
2 min read
1 of 73,686
Next
